- Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks. Moroz, C., Grunspan, A., Zahalka, M.A., Traub, L., Kodman, Y., Yaniv, I. Exp. Hematol. (2006)